Starting next year, U.S. clinical laboratories including hospital outreach labs are facing a number of significant challenges now that the Centers for Medicare & Medicaid Services has made a significant change in its new market-based pricing system (PAMA) that will require virtually all outreach programs to begin collecting private payor data starting next year.
While this could poteny high-volume lab tests already set for both 2019 and 2020. In addition, CMS has yet to announce whether it will impose civil monetary penalties up to $10,000 per day for labs required to report data but fail to do so. These issues along with other key lab reimbursement challenges will be the focus of a national webinar I’ll be chairing on Nov 29, “The Bottom Line for Lab Reimbursement in 2019: When All Is Said & Done With PAMA.” The program will feature a trio of nationally known lab experts and will run from 2:00 – 3:15 pm EST. For details & registration details, visit www.laboratoryeconomics.com or call 1-845-463- 0080.